Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.25
Bid: 14.00
Ask: 14.50
Change: 0.00 (0.00%)
Spread: 0.50 (3.571%)
Open: 14.25
High: 14.25
Low: 14.25
Prev. Close: 14.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: US Stocks Seen Up Ahead Of Amazon, GM, AT&T

Thu, 23rd Jul 2015 11:23

LONDON (Alliance News) - UK shares are slightly higher Thursday midday, as UK publisher Pearson confirmed it is in talks to sell the FT Group, while Wall Street is called for a positive open ahead of another big day for US earnings reports.

Pearson confirmed it is in advanced discussions over the potential sale of the FT Group, consisting of the Financial Times, a 50% shareholding in The Economist Group and the Vedomosti joint venture in Russia.

However, it provided no details of with whom it is in discussions, and said there can be no certainty these talks will lead to a sale. "A further announcement will be made if and when appropriate," the company said. The statement follows a report from Reuters that Pearson was set to announce a sale of the Financial Times "imminently" to a "global digital news company".

Shares in Pearson are up 1.9% at 1,231 pence. Following the announcement, the stock reached a peak of 1,255.00p having traded at 1,210p prior to the Reuters report.

The FTSE 100 is up 0.2% at 6,680.45 points, the FTSE 250 is up 0.1% at 17,664.31, and the AIM All-Share is up 0.3% at 755.34. Similarly, European major indices also are enjoying modest gains, with the CAC 40 in Paris up 0.2% and the DAX 30 in Frankfurt up 0.1%.

US futures point to a higher open, with the DJIA and the S&P 500 both pointed up 0.2% and the Nasdaq 100 up 0.3%. Thursday is set to be one of the busiest days of the earnings season for the S&P 500, as investors await reports from Amazon.com, AT&T, Caterpillar, GM and McDonald's.

Both the S&P 500 and the Nasdaq Composite index are close to record highs, but CMC Markets analyst Jasper Lawler says, "the badly received results from Apple, coupled with the rout in commodities is hampering the possibility of a break out."

"That said, there is a slight recovery in the gold price today and a second set of conditions for a Greek bailout have been approved by the government in Athens," writes the analyst. "This backdrop alongside better corporate results on Thursday could be enough to spark a bigger turnaround."

The price of gold has recovered some ground since the sell-off earlier this week. The yellow metal is quoted at USD1,102.16 Thursday midday, having touched a low of USD1,073.40 on Monday.

FTSE 100-listed gold miners Fresnillo, up 1.8%, and Randgold Resources, up 1.7%, are benefiting from the rise in gold prices. In the FTSE 250, Acacia Mining, up 2.3%, and Lonmin, up 2.3%, are amongst the biggest mid-cap risers.

Unilever shares are up 2.2% after its results beat expectations. The consumer goods group posted underlying sales growth of 2.9% in its first-half, slightly ahead of the consensus for 2.7% growth, while second-quarter underlying sales growth, also of 2.9%, beat consensus estimates for 2.6% growth. The underlying figures strip out the impact of currency movements and any acquisitions or disposals.

Aberdeen Asset Management is the worst performer in the FTSE 100, trading down 7.9%, having hit its lowest level in over a year. The company said its assets under management dropped in the third quarter of its financial years amid outflows related to volatility in Asian and emerging markets.

Aberdeen said its assets under management fell to GBP307.3 billion at the end of June, down from GBP330.6 billion at the end of March. Aberdeen attributed the fall to market conditions and foreign exchange movements.

In the AIM All-Share, Victoria Oil & Gas is up 5.9%. The gas utility company said both gas production and sales more than doubled in the second quarter of 2015. Average gas production in the second quarter was 12.6 million standard cubic feet per day. That is more than double the 4.5 million cubic feet produced in the first quarter of 2015 and the 2.6 million produced a year earlier. Gas sales also leapt to 1.12 billion standard cubic feet from only 404.5 million cubic feet in the previous quarter and from 281.1 million cubic feet a year earlier.

Angle is down 3.2%. The company posted a widened pretax loss for its recently ended financial year, as it continued to progress its Parsortix cell separation system towards commercialisation. For the year to end-April the company posted a pretax loss of GBP3.9 million, widened from a pretax loss GBP2.2 million a year before, due to an increase in operating costs, as it increased investment in developing its key product Parsortix.

Outside corporate news, the pound took a hit against other major currencies following a disappointing set of UK retail sales figures for June.

Data from the Office for National Statistics showed that UK retail sales declined 0.2% from the prior month, reversing a 0.3% rise in May. This was the first drop in three months and went against expectations of a 0.4% gain. On a yearly basis, growth in retail sales including automotive fuel eased unexpectedly to 4.0% from 4.7% in May. Economists had expected 4.8% expansion.

The pound is down against the dollar at USD1.5596 from USD1.5652 before the data. Against the euro the pound slipped to a low of EUR1.4167 and is quoted Thursday midday at USD1.4185.

In Greece, the country's parliament overwhelmingly approved a second set of reforms needed to start talks on a third multi-billion euro bailout in the early hours of Thursday. The reforms, which are the final requirement before the country can start the bailout negotiations with its creditors, included lifting of liquidity of banks, deposit security and renewing of the judicial system. In the 300-seat parliament, 230 lawmakers voted in favour of the bill, with support for the ruling party coming from the pro-euro opposition parties.

In addition, the European Central Bank reportedly provided a vital new cash injection to Greece's liquidity-starved banks on Wednesday, the second such cash injection in just under a week.

Still ahead in the economic calendar, in the US, are initial and continuing jobless claims at 1330 BST and the US Conference Board leading indicator at 1500 BST, alongside eurozone consumer confidence.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2022 10:27

Angle wins additional contract with large-scale pharma company

(Sharecast News) - Liquid biopsy company Angle has secured an additional contract with its first large-scale pharmaceutical services customer.

Read more
22 Jun 2022 10:01

Angle wins cancer monitoring contract for Parasortix system

(Alliance News) - Angle PLC on Wednesday said it has secured further business with its "first large scale pharma services" customer.

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
14 Jun 2022 20:13

IN BRIEF: Angle's Parsortix performs well on prostate cancer patients

Angle PLC - Surrey, England-based medical diagnostics company - Notes researchers at King's College London published data investigating the role of invasive cellular protrusion, known as invadopodia, activity in prostate cancer, and a potential role in the formation of circulating tumour cells. Researchers used Angle's Parsortix system's ability to isolate CTCs from the blood of prostate cancer patients. Parsortix system isolates CTCs in 94% of prostate cancer patients, showing some association with matrix degradation and invasive cellular protrusion formation. This may allow novel therapeutic development targeting the mechanisms of invadopodia and reducing metastatic spread of the cancer, it says.

Read more
30 May 2022 15:21

IN BRIEF: Angle partners with US urology group for Parasortix study

Angle PLC - Surrey, England-based medical diagnostics company - Establishes partnership with MidLantic Urology to evaluate the use of its Parasortix system in prostate cancer clinical studies. MidLantic is as an affiliate of special urology services provider Solaris, which has over 500 clinical urology providers across 179 locations in the US, with over 729,000 annual patients. Angle hopes the collaboration will "enable potential sales" to Solaris' patient base. The first study is expected to start in the third quarter of 2022, with results to be available in 2023.

Read more
27 May 2022 21:25

TRADING UPDATES: Savannah Energy to develop new projects in Chad

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
25 May 2022 21:19

IN BRIEF: Angle shares rocket as Parasortix receives US FDA approval

Angle PLC - Surrey, England-based medical diagnostics company - Receives approval from the US Food & Drug Administration for the use of its Parasortix system for use in metastatic breast cancer patients. Parasortix isolates circulating tumour cells from the blood which can aid in the diagnosis, characterisation and monitoring of cancer, and do so in a much less invasive fashion than traditional tissue biospy.

Read more
25 May 2022 17:06

LONDON MARKET CLOSE: Stocks rise ahead of US Fed meeting minutes

(Alliance News) - Stocks in London ended mostly higher on Wednesday as market participants look ahead to the latest minutes from the US Federal Reserve at 1900 BST.

Read more
20 May 2022 13:07

Angle's Parsortix to be used in 'significant' prostate cancer study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that Prostate Cancer UK has approved funding for a "significant" clinical study at the Barts Cancer Institute of the Queen Mary University of London.

Read more
20 May 2022 09:48

IN BRIEF: Cancer study using Angle's Parasortix secures funding

Angle PLC - Surrey, England-based medical diagnostics company - Says Prostate Cancer UK has given a GBP750,000 grant for a clinical study at Barts Cancer Institute, Queen Mary University of London. The trial will follow 200 men with localised prostate cancer over five years, assessed using Angle's Parsortix system, in bid to see whether the cancer will eventually spread.

Read more
28 Apr 2022 16:10

EARNINGS UPDATES: Brave Bison notes first profit; Angle widens loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
21 Apr 2022 16:10

UK earnings, trading statements calendar - next 7 days

Friday 22 April 
Alphawave IP Group PLCFull Year Results
Petropavlovsk PLCTrading Statement
Record PLCTrading Statement
Serabi Gold PLCFull Year Results
Zinc Media Group PLCFull Year Results
Monday 25 April 
Access Intelligence PLCFull Year Results
Arecor Therapeutics PLCFull Year Results
Audioboom Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Chapel Down Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Vector Capital PLCFull Year Results
Tuesday 26 April 
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Billington Holdings PLCFull Year Results
Corero Network Security PLCFull Year Results
Focusrite PLCHalf Year Results
Futura Medical PLCFull Year Results
Gaming Realms PLCFull Year Results
Hochschild Mining PLCTrading Statement
HSBC Holdings PLCQ1 Results (at 0500 BST)
Immotion Group PLCFull Year Results
IWG PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Learning Technologies Group PLCFull Year Results
Loungers PLCTrading Statement
National Express Group PLCTrading Statement
Northcoders Group PLCFull Year Results
Nostrum Oil & Gas PLCFull Year Results
PureTech Health PLCFull Year Results
RWS Holdings PLCHalf Year Results
Taylor Wimpey PLCFull Year Results
Wednesday 27 April 
1Spatial PLCFull Year Results
AB Dynamics PLCHalf Year Results
Anglo Pacific Group PLCQ1 Results
Aveva Group PLCTrading Statement
City Pub Group PLCFull Year Results
Drax Group PLCTrading Statement
Fresnillo PLCQ1 Production Results
GlaxoSmithKline PLCQ1 Results
Go-Ahead Group PLCHalf Year Results
Lloyds Banking Group PLCQ1 Results
London Stock Exchange Group PLCTrading Statement
Network International Holdings PLCTrading Statement
Nichols PLCFull Year Results
Persimmon PLCTrading Statement
Primary Health Properties PLCTrading Statement
RPS Group PLCQ1 Results
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Yamana Gold IncTrading Statement
Thursday 28 April 
Angle PLCFull Year Results
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
C4X Discovery Holdings PLCHalf Year Results
Evraz PLCQ1 Results
Flutter Entertainment PLCQ1 Results
Glencore PLCTrading Statement
Howden Joinery Group PLCTrading Statement
HSS Hire Group PLCFull Year Results
Hurricane Energy PLCFull Year Results
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
International Personal Finance PLCTrading Statement
J Sainsbury PLCFull Year Results
Keystone Law Group PLCFull Year Results
Lancashire Holdings LtdQ1 Trading Statement
Novacyt SAFull Year Results
PPHE Hotel Group LtdTrading Statement
Sanderson Design Group PLCFull Year Results
Schroders PLCTrading Statement
Smith & Nephew PLCQ1 Results
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Standard Chartered PLCQ1 Results
Unilever PLCQ1 Results
Whitbread PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Apr 2022 12:25

TRADING UPDATES: Yooma, Love Hemp in UK boost; Peel Hunt tops forecast

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
29 Mar 2022 19:29

IN BRIEF: Angle's Parsortix can help with cancer treatment options

Angle PLC - Surrey, England-based medical diagnostics company - Notes University of Maryland Marlene and Stewart Greenebaum NCI Comprehensive Cancer Institute has published results of work undertaken in preclinical models of triple-negative breast cancer. Findings show isolation of live circulating tumour cells from a simple blood draw, using Angle's Parsortix system, can provide rapid information on patient response to existing chemotherapy treatments that can target metastasis more effectively than tumour growth.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.